Gottlieb D J, DeStefano A L, Foley D J, Mignot E, Redline S, Givelber R J, Young T
The Pulmonary Center, Boston University School of Medicine and VA Boston Healthcare System, MA 02118-2394, USA.
Neurology. 2004 Aug 24;63(4):664-8. doi: 10.1212/01.wnl.0000134671.99649.32.
Obstructive sleep apnea/hypopnea (OSAH) has a strong heritable component, although its genetic basis remains largely unknown. One epidemiologic study found a significant association between the APOE epsilon4 allele and OSAH in middle-aged adults, a finding that was not replicated in a cohort of elderly adults. The objective of this study was to further examine the association of the APOE epsilon4 allele with OSAH in a community-dwelling cohort, exploring age dependency of the association.
A genetic association study was performed, nested within a prospective cohort study of the cardiovascular consequences of OSAH. Unattended, in-home nocturnal polysomnography was used to measure apnea-hypopnea index (AHI) in 1,775 participants age 40 to 100 years. OSAH was defined as an AHI > or = 15. The relation of APOE genotype to prevalent OSAH was analyzed using generalized estimating equations to account for non-independent observations of individuals from the same sibship.
At least one APOE epsilon4 allele was present in 25% of subjects, with 1.3% epsilon4/epsilon4 homozygotes. The prevalence of OSAH was 19%. After adjustment for age, sex, and BMI, the presence of any APOE epsilon4 allele was associated with increased odds of OSAH (OR 1.41, 95% CI 1.06 to 1.87, p = 0.02). The effect was approximately twice as great in subjects <75 (OR 1.61, CI 1.02 to 2.54) as in those > or =75 years old (OR 1.32, CI 0.91 to 1.90). Exploratory analyses revealed that the strongest effect of APOE epsilon4 was in subjects age <65 (OR 3.08, CI 1.43 to 6.64), and was stronger in those with hypertension or cardiovascular disease than in those without.
The APOE epsilon4 allele is associated with increased risk of OSAH, particularly in individuals under age 65. The mechanisms underlying this association are uncertain. Age-dependency of the APOE-OSAH association may explain previous conflicting results.
阻塞性睡眠呼吸暂停/低通气(OSAH)具有很强的遗传成分,但其遗传基础仍大多未知。一项流行病学研究发现,载脂蛋白E(APOE)ε4等位基因与中年成年人的OSAH之间存在显著关联,但这一发现未在老年人群队列中得到重复验证。本研究的目的是在一个社区居住队列中进一步研究APOE ε4等位基因与OSAH的关联,并探讨该关联的年龄依赖性。
进行了一项基因关联研究,该研究嵌套于一项关于OSAH心血管后果的前瞻性队列研究中。采用无人值守的家庭夜间多导睡眠图来测量1775名年龄在40至100岁之间参与者的呼吸暂停低通气指数(AHI)。OSAH定义为AHI≥15。使用广义估计方程分析APOE基因型与现患OSAH的关系,以考虑来自同一同胞关系个体的非独立观察值。
25%的受试者存在至少一个APOE ε4等位基因,其中1.3%为ε4/ε4纯合子。OSAH的患病率为19%。在调整年龄、性别和体重指数后,任何APOE ε4等位基因的存在都与OSAH的患病几率增加相关(比值比[OR]为1.41,95%置信区间[CI]为1.06至1.87,p = 0.02)。年龄<75岁的受试者中该效应约为≥75岁受试者的两倍(OR分别为1.61和1.32,CI分别为1.02至2.54和0.91至1.90)。探索性分析显示,APOE ε4的最强效应出现在年龄<65岁的受试者中(OR为3.08,CI为1.43至6.64),且在患有高血压或心血管疾病的受试者中比未患这些疾病的受试者更强。
APOE ε4等位基因与OSAH风险增加相关,尤其是在65岁以下个体中。这种关联的潜在机制尚不确定。APOE与OSAH关联的年龄依赖性可能解释了先前相互矛盾的结果。